Therapeutic ion channel blocking agents and methods of use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 24, 2009
Grant Date -
Nov 24, 2005
app pub date -
Mar 20, 2003
filing date -
Mar 20, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Various divalent ligands based on khellinone derivatives are described. These derivatives can be useful in the modulation of potassium channel activity in cells, including among others Kv1.3 channels found in T-cells. The compounds may also be useful in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully